Related Topics News -

     
 Title only   |   Print 
     
泰格醫藥董事計劃減持A股 上限300萬股

2025-07-28T  
泰格醫藥入股MICRON 56.37% 對價4.8億日圓

2025-07-28T  
泰格醫藥所屬投資平台悉售禮新醫藥3.41% 作價3,411萬美元

2025-07-17T  
《大行》花旗看好中國醫療板塊 首選藥明康德藥明生物

2025-07-11T  
《大行》交銀國際:南向資金近月主力配置集中醫療和金融板塊 反映對高息防禦價值重視

2025-07-04T  
《大行》匯豐研究:創新藥臨床試驗需求正轉向中國 上調泰格醫藥目標價至41.8元

2025-06-20T  
泰格醫藥H股末期息支付日期改為7月11日

2025-06-19T  
《大行》大和升泰格醫藥目標價至38元 續籲「持有」

2025-06-13T  
《大行》美銀上調再鼎醫藥目標價至29.61元 升泰格醫藥目標價至40.1元

2025-06-11T  
《大行》大摩列康龍化成為中型CRO/CDMO首選股 長期看好昭衍泰格

2025-06-10T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.